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1. Introduction
  Vascular injury is one of the critical causes of 
atherosclerosis and stenosis after vascular surgery[1]. When 
a blood vessel is injured, the adjacent endothelial cells 
can repair it[2]. However, since the endothelial cells were 
highly differentiated, the repair capacity is limited. It was 
found recently that it is the EPCs that migrate and recruited 
into the injury, and achieve vascular repair finally after 
vascular injury[3,4]. Therefore, it is beneficial to promote 
its application in clinical practice by investigating the 
mechanism of the proliferation and migration activity of 
endothelial progenitor cells (EPCs). So far, it is known that 
the function of EPCs is regulated by many known factors, 
such as vascular endothelial growth factor, fibroblast growth 
factor, and estrogen level of apolipoprotein and CCNI[5-7]. 
However, there is not yet a thorough theory to explain 
the mechanism regulating EPCs’ proliferation, migration, 
especially in the view of ion channel. It has been confirmed 
that the calcium ion is involved with the regulation of 
cell proliferation, migration function. According to the 
latest report, calcium is also involved in the regulation of 
proliferation and migration of EPCs. We conclude that the 
function of EPCs may be subject to the regulation of the 
calcium ion channels (SOCs). SOCs are mainly composed of 
three families, among which stromal interaction molecule 
1(STIM1) is the major family since STIM1 is the receptor of 
Objective: To investigate the effect of stromal interaction molecule 1(STIM1) knockdown on 
the proliferation and migration of endothelial progenitor cells (EPCs) after vascular injury and 
its mechanism. Methods: The rat bone marrow derived EPCs were divided into three groups: 
adenovirus negative control (group NSC), rat STIM1 adenovirus vector transfection group 
(group si/rSTIM1) and rat &human recombinant STIM1 adenovirus transfection group (group si/
rSTIM1+hSTIM1). The STIM1 expressions in each group were detected by reverse transcription 
PCR after transfection; the cell proliferation was tested by [3H] thymidine incorporation assay (3H-
TdR); Cell cycle was analyzed by flow cytometry; the cells’ migration activity was detected by 
Boyden assay; Calcium ion concentration was detected by using laser confocal method. Results: 
48 h later after transfection, the expression level of STIM1 in si/rSTIM1 cells was significantly 
lower than that in NSC group (0.21依0.12 vs 1.01依0.01, P<0.05); EPCs that stayed in G1 phase in 
si/rSTIM1 group [(93.31依0.24)%] were significantly more than that in NSC group [(78.03依0.34)%, 
P<0.05]; EPCs’ migration activity in si/rSTIM1 group (10.03依0.33) was significantly lower than that 
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there was no significant difference between si/rSTIM1+hSTIM1 group and NSC group on the four 
indexes above. Conclusions: Silence of STIM1 attenuates EPCs proliferation and migration after 
vascular injury, by mediating the calcium ion concentration in EPCs.
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SOCs. STIM1 plays a key role to accept, transfer internal and 
external information of the cells. It has been demonstrated 
that STIM1 silencing can attenuate the calcium influx of the 
vascular smooth muscle cells (SMCs), resulting in impaired 
muscle cell proliferation, thereby inhibiting neointimal 
thickening after vascular injury[8,9]. Meanwhile it is reported 
that knockdown of STIM1 could inhibit the proliferation 
and migration of EPCs induced by hepatocyte growth factor. 
Additionally, a new study has been found that silencing 
STIM1 inhibited the proliferation and migration of EPCs[10,11]. 
Nevertheless, it is still lack of satisfactory reports regarding 
how EPCs regulated by STIM1 and its mechanism. In this 
study, we try to explore the regulation and mechanism of 
STIM1 on EPCs through analyzing changes in cell behavior 
after the knockdown of STIM1 and detecting (calcium) 
changes on molecular level. The study provides a more 
thorough mechanism for modulating the biological properties 
of EPCs and indicates that STIM1 may be a new target for 
inducing vascular repair by EPCs.
2. Materials and methods 
2.1. Isolation and characterization of EPCs
  Isolation and identification of rat bone marrow stem cell 
process was described in Figure 1. Mononuclear cells were 
extracted from the bone marrow of femur and tibia by using 
concentration gradient centrifugation (400 g, 2 min). Then 
those cells were be cultured in DMEM-L selective medium. 
Finally EPCs were identified if the cell was positive for both 
Dil-AcLDL and fluorescein isothiocyanate-labeled lectin.
2.2. Adenovirus transfection
  All of the animal experiments were approved by the Care 
of Experimental Animals Committee of our school. Three 
kinds of adenovirus NSC, rSTIM1, hSTIM1 (Ad) vector were 
constructed in our laboratory. The isolated EPCs were 
divided into three groups, and were transfected with Ad-si/
rSTIM1, Ad-si/rSTIM1+hSTIM1 and NSC respectively, which 
were used in the subsequent experiments 48 h later.
2.3. Detection of STIM1 mRNA level using reverse transcript 
PCR.
  The total RNA were extracted using Taco RNA Extraction 
Kit (provided by Harbin De Yuan Science and Technology 
Development Co Ltd), which was followed by cDNA synthesis 
with Clontech Kit (provided by Clonetech), PCR and 
electrophoresis. The primers used were as follows: STIMI1 
upstream primer 5’-GACCCATTCCGATTC-3’, downstream 
primer 5’-GGCTATGAGAATGGGAAGA-3’; using rat B-actin 
as the reference. All primers were synthesized by Invitrogen 
company.
2.4. Cell proliferation of[3H] thymidine incorporation method
  [3H] concentration was detected to measure the synthesis 
of DNA in EPCs. EPCs were cultured in serum free culture 
for 24 h, then EPCs in each group were seeded onto the 96-
hole plate and cultured for 40 h. Each hole then was added 
with 1 毺Ci of[methyl -
3
H] thymidine. After another 8 h of 
culture, 3H-methyl thymidine was precipitated by 10% three 
trichloroacetic acid. With a liquid scintillation counter, 
eventually, cells with 3H were counted at 0, 24, 48 and 72 h, 
respectively, with a liquid scintillation counter. All groups of 
experiments were performed in triplicate.
2.5. Analysis of cell cycle with flow cytometry
  EPCs were digested by the trypsin, following by 1 500 g
centrifugation for 5 min, PBS cleaning, finally, fixation 
overnight with 70% alcohol under 4 ℃. Then the nucleus was 
again with PBS, and was incubated with 0.1% sodium citrate 
in the chamber at room temperature (0.05 mg PI and 100 
mg/mL RNase) for 30min. subsequently, the analysis of the 
fluorescence was done with the flow cytometry. The number 
of cells in each phase were analyzed with automatic analysis 
software (Cell-FIT software), which is specific for analyzing 
the cell cycle.
2.6. Cell migration detected with Boyden assay
  48 hours after transfection, the EPCs (2×105/mL) were 
dissolved in DMEM-L without serum, and then they were 
put into the upper ward of modified Boyden chambers. 
Afterwards, the lower chamber was placed with 20% FCS 
and DMEM-L. After 6 h, micro membrane was removed 
and washed with PBS. And then cells in the lower chamber 
were fixed with ethanol and stained with hematoxylin for 
3 min. The cells that migrated from the upper chamber to 
the lower chamber were counted with the micro device. The 
average value of each five randomly selected vision was 
calculated as the final value and all experimental groups 
were performed in triplicate.
2.7. Calcium ion concentration in EPCs tested by confocal 
laser 
  The EPCs were incubated in Fluo-3/AM (Ca2+ indicator) 
solution for 30 min within the condition of 37 ℃ and 5% CO2. 
After rinsing the cells with D-Hanks liquid, those cells were 
cultured under the same conditions for 30 min. Eventually 
the fluorescence intensity of Fluo-3/AM was recorded at 
room temperature with micro laser confocal microscope 
(LSCM) when the excitation wavelength was 488 nm. Changes 
in the intensity of fluorescence in EPCs demonstrated the 
changes of the concentration of Ca2+ in EPCs. In addition, 
before the experiment was done 5 mM nifedipine was added 
to the EPCs to inhibit L- channel activity. All groups of 
experiments were performed in triplicate. 
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2.8. Statistical analysis 
  Data from at least three independent experiments were 
expressed as mean依SD and SPSS 11.0 software was used 
for statistical analysis. Data were analyzed in pairs (test 
and control) using t-tests. P<0.05 was considered to be 
statistically significant. 
3. Results   
3.1. Expression of STIM1 in the EPCs-the transfection 
efficiency of STIM1 
  After 4-7 days of culture, EPCs were identified by flow 
cytometry and LSCM. Cells that were positive both for Dil-
AcLDL and lectin weighted for (91.4依1.67)% (Figure 2). And 
expressed endothelial/stem cell markers including CD133 
(90.86%), VEGFR-2 (90.12%), CD34 (78.62%). 
  The EPCs were divided into three groups (10 MOI): Ad-si/
rSTIM1, (5 MOI+5 MOI) Ad-si/rSTIM1+ hSTIM1 and (10 MOI) 
and NSC.48 h later. The expression of STIM1 in EPCs was 
detected by semi quantitative reverse transcription PCR. The 
results were shown at Figure 3: Compared with NSC group 
(1.01依0.01), STIM1 mRNA in Ad-si/rSTIM1 group (0.20依0.12) 
was decreased obviously (P=0.000, t=5.734). (5 MOI+5 MOI) 
mRNA level of STIM1 in Ad-si/rSTIM1+ hSTIM1 group was 
(0.95依0.13) reversed to the level of NSC group.
3.2. STIM1 silencing inhibited the proliferation and 
migration of EPCs and extended the Gl phase of the cell cycle
  EPCs were divided into three groups: Ad-si/rSTIM1, Ad-si/
rSTIM1+hSTIM1 and NSC. After 48 h, the EPCs’ proliferation 
was detected by of the intaked 3H-TdR. Cell cycle changes 
were observed by flow cytometry and migration of EPCs 
by using Boyden assay. 3H-TdR test results: 3H-TdR 
incorporation in EPCs of Ad-si/rSTIM1 group (2 439.03依
120.32) was significantly lower than that of the NSC group
(6 890.43依256.43). The difference was statistically significant 
(P=0.002, t=5.208). While 3H-TdR incorporation in group of 
Ad-si/rSTIM1+hSTIM1 (6 782.00依267.36) was as much as that 
in NSC group (P=0.12), which indicated that the silencing of 
STIM1 suppressed EPCs’ proliferation ability.
  Flow cytometry result: the number of cells that distributed 
in G1 phase[(93.31依0.24)%] in the Ad-si/rSTIM1 transfection 
group was significantly higher than that in the NSC group 
(78.03依0.34)%. The difference was statistically significant 
(P=0.0001, t=6.234). Moreover, the number of cells in S 
phase (2.14依0.03) was significantly lower than that of NSC 
group (14.56依0.23), and the difference was statistically 
significant (P=0.0001, t=7.120). The number of cells in Ad-si/
rSTIM1+hSTIM1 group distribution in G1 and S phase[(79.00
依0.43)%; (14.54依0.06)%] showed no significant difference 
(P=0.2310, t=6.513) compared with the NSC group.    
  Subsequently, modified Boyden chambers were used to 
assess the effects of STIM1 on EPC migration. The number 
of EPCs migration cells in Ad-si/rSTIM1 transfection group 
(10.03依0.33) was significantly lower than that in NSC group 
(32.11依0.54), and the difference was statistically significant 
(P=0.003, t=5.423), while the number of migration cells in 
Ad-si/rSTIM1+hSTIM1 group (33.21依0.65) was close to that of 
NSC group. These results demonstrated that knockdown of 
STIM1 inhibited the migration of EPCs in vitro.
Figure 1. Schematic of the isolation of EPCs.
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Figure 2. Characterization of EPCs.
Note: EPCs showing uptake of acetylated LDL (red) and lectin (green) 
binding[(91.4依1.67)%], n= 3; 3 random fields per well.
1                                 2                                 3
毬-actin
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Figure 3. Expression of STIM1 in EPCs.
1: NSC group, 2: Ad-si/rSTIM1 group, 3: Ad-si/rSTIM1+ hSTIM1 
group.
Note: the expression of STIM1 mRNA was studied using semi-
quantitative RT-PCR. Transduction of EPCs with Ad-si/rSTIM1 
significantly degraded STIM1 mRNA expression at 48 h post-
transduction. On the rSTIM1-knockdown background, hSTIM1 re-
expression reversed the effects of STIM1 knockdown on STIM1 mRNA 
expression levels. Co-transfection of Ad-hSTIM1 (MOI 5 pfu/cell) with 
Ad-si/rSTIM1 (MOI 5 pfu/cell) restored the expression of mRNA and 
protein in EPCs (n=3).
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3.3. Change of cell calcium concentration
  48 h after transfection, finally, we evaluated the effect of 
si/rSTIM1 on SOCE, which was activated by the depletion of 
intracellular Ca2+ stores. Then extracellular Ca2+ was added 
to EPCs culture to a concentration of 5 mmol/L. The changes 
of calcium ion concentration were detected by the laser 
confocal fluorescence. The results showed that: the change 
of Ca2+ concentration in EPCs of Ad-si/rSTIM1 transfected 
group (38.03依0.13) was lower than that in NSC group (98.11
依0.34), and the difference was statistically significant 
(P=0.000, t=15.007). Interestingly, there was no significant 
difference between the Ca2+ change of Ad-si/rSTIM1+hSTIM1 
group (97.75依0.25) and that of NSC group. These results 
demonstrated that on the si/rSTIM1 background, the co-
transfection of cells with Ad-hSTIM1 reversed the effects 
of STIM1 knockdown on intracellular Ca2+ in EPCs. These 
results demonstrated that SOCE might play a key role in the 
proliferation and migration of EPCs.
 
4. Discussion
  This study mainly evaluated the potential involvement of 
STIM1 in EPCs cell function and its mechanism through RNA 
interference silencing STIM1. According to this purpose, 
detections were performed as following described. Firstly, 
the proliferation of the EPCs was detected by testing the[3H] 
thymidine incorporation. Additionally, cell cycle of the EPCs 
of each group was further investigated by flow cytometry. 
Meanwhile, we studied the changes of EPCs migration 
activity after knockdown of STIM1 by using Boyden assay. 
Additionally, to figure out the mechanism that the STIM1’s 
regulation on EPCs, we also detected the Ca2+ concentration 
change with confocal laser scanning method after silencing 
STIM1 in EPCs. We hope to explore the effects of STIM1 on 
the proliferation and migration of EPCs cells, thus achieve 
more comprehensive understanding of EPCs on the repair 
of vascular injury to provide a new theoretical guidance for 
clinical. 
4.1. Mechanism of the vascular endothelial injury 
  The bad repair of endothelial injury and vascular injury 
are two of the most common pathological and physiological 
basis of coronary heart disease and other vascular injury 
diseases[12,13]. It is a crucial step to prevent and cure the 
disease to repair the damaged endothelial, promoting re 
endothelialization. However, vascular injury repair process 
is complex and it is generally considered to be a variety of 
mechanisms involved in this process. Among them, intimal 
neovascularization slowly re-endothelialization is an 
important pathological mechanism of adverse cardiovascular 
remodeling[14,15]. Therefore, the prevention and cure of the 
vascular endothelial injury can be achieved by promoting 
re-endothelialization as soon as possible, which meanwhile 
inhibited the proliferation of the smooth muscle cells. So 
far, research on EPCs has confirmed that the proliferation, 
migration, homing characteristics of EPCs doomed its 
function on repairing the vascular endothelial injury[16-
18]. However, few thorough researches were reported on 
the regulation of STIM1 on EPCs and its mechanism, which 
has seriously hindered the clinical application of EPCs. 
Therefore, further study of the molecular mechanism of 
the biological behavior of EPCs is of great importance on 
providing a more detailed regulatory mechanism that may 
induce new drug targets.
4.2. Analysis of the EPCs proliferation, migration and Ca2+ 
concentration after knockdown of STIM1
  After silencing STIM1, the 3H-TdR intake of the EPCs was 
significantly decreased (P<0.05), the number of cells that 
stay in G1 phase increased significantly compared with 
the control group (P<0.05), and the EPCs migration ability 
also significantly decreased (P<0.05). The results showed 
that knockdown of STIM1 can inhibit the proliferation 
and migration of EPCs, which is consistent with the Oh-
Hora’s report[19]. He reported that STIM1 regulated the 
normal development on various cells. When T cells were 
lack of STIM1, the secretion of cytokines and nuclear factor 
were significantly reduced, therefore the T cells growth 
was inhibited. Guo et al[20] also reported that inhibiting 
expression of STIM1 by RNA interference in smooth muscle 
cell resulted in lower Ca2+ concentration than that of the 
control group. Lacking of Ca2+, smooth muscle cells were 
arrested in the G0/G1 phase, which eventually led to the 
inhibition of the proliferation of smooth muscle cells, and 
also migration. In this study by silencing of STIM1 in EPCs, 
the proliferation and migration of EPCs were decreased and 
the expression of human STIM1 had reversed these effects. 
These results further demonstrated that, STIM1 is a critical 
regulatory factor in EPCs biological behavior. 
  In addition, the results also showed that the silence of 
STIM1 could reduce Ca2+ internal flow, but the expression 
of human STIM1 could restore it. This suggested that STIM1 
may regulate EPCs’ proliferation and migration through 
the regulation of Ca2+. As is known calcium is essential 
for the biological behavior of second messenger in cell 
proliferation, migration, differentiation[21-24]. EPCs calcium 
channel mainly is based on SOCs[25]. STIM is an important 
part of the SOCs. By inference, silencing of STIM1 is likely to 
inhibit the activity of the SOCs in EPCs, and then Ca2+ influx 
was inhibited. With Ca2+ as the second messenger pathway 
restricted, cell proliferation and migration pathways were 
surely to be affected.
4.3. Problems and prospects of the study 
  It is unclear yet that weather STIM1 is acting together 
with other factors to regulate the internal flow of Ca2+. 
Konstantinos also speculate that STIM1 may involve with 
cAMP signal pathways[26-28]. Therefore, further studies are 
needed to understand more detailed regulatory mechanisms 
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which referring to other signaling pathways in combination 
with STIM1.
4.4. Conclusions
  In summary, silencing of STIM1 can inhibit the proliferation 
and migration of EPCs after vascular injury. The effect of 
STIM1 on the regulation of EPCs mainly achieved through 
the regulation of calcium intracellular implementation. 
This is the first study to better elucidate the mechanism of 
EPCs repair after vascular endothelial injury, providing a 
theoretical basis for the clinical new therapeutic targets.
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